PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

Eun Joo Shin; Chu Xuan Duong; Xuan Khanh Thi Nguyen; Guoying Bing; Jae Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F. Ali; Anumantha G. Kanthasamy; Jean L. Cadet; Toshitaka Nabeshima; Hyoung Chun Kim

doi:10.1016/j.neuint.2011.03.022

PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

Eun Joo Shin
, Chu Xuan Duong
, Xuan Khanh Thi Nguyen
, Guoying Bing
, Jae Hyung Bach
, Dae Hun Park
, Keiichi Nakayama
, Syed F. Ali
, Anumantha G. Kanthasamy
, Jean L. Cadet
, Toshitaka Nabeshima
, Hyoung Chun Kim

Neuroscience

Producción científica: Article › revisión exhaustiva

40 Citas (Scopus)

Resumen

The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

Idioma original	English
Páginas (desde-hasta)	39-50
Número de páginas	12
Publicación	Neurochemistry International
Volumen	59
N.º	1
DOI	https://doi.org/10.1016/j.neuint.2011.03.022
Estado	Published - ago 2011

Nota bibliográfica

Funding Information:
This study was supported by a Grant (#2011K000271) from the Brain Research Center from 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and by a Grant (#E00025) of the Korea-Japan Joint Research Program, National Research Foundation of Korea, Republic of Korea. This work was, in part, supported by grants from Ministry of Health Labour and Welfare (MHLW): Research on Risk of Chemical Substances, and Ministry of Education, Culture, Sports, Science and Technology (MEXT): Academic Frontier Project. Xuan-Khanh Thi Nguyen and Jae-Hyung Bach were supported by BK 21 Program.

Financiación

This study was supported by a Grant (#2011K000271) from the Brain Research Center from 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and by a Grant (#E00025) of the Korea-Japan Joint Research Program, National Research Foundation of Korea, Republic of Korea. This work was, in part, supported by grants from Ministry of Health Labour and Welfare (MHLW): Research on Risk of Chemical Substances, and Ministry of Education, Culture, Sports, Science and Technology (MEXT): Academic Frontier Project. Xuan-Khanh Thi Nguyen and Jae-Hyung Bach were supported by BK 21 Program.

Financiadores	Número del financiador
National Institute on Drug Abuse	ZIADA000551
Ministry of Education, Culture, Sports, Science and Technology
Ministry of Health, Labour and Welfare
National Research Foundation of Korea
Ministry of Science and Technology, Croatia	00025

ASJC Scopus subject areas

Cellular and Molecular Neuroscience
Cell Biology

Acceder al documento

10.1016/j.neuint.2011.03.022

Otros archivos y enlaces

Citar esto

@article{cc2e1ecb281948eba33a7634fb05e0a4,

title = "PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment",

abstract = "The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.",

keywords = "Dopaminergic toxicity, Hyperthermia, Methamphetamine, PKCδ gene, Phospho-TH at ser-40, Striatum",

author = "Shin, \{Eun Joo\} and Duong, \{Chu Xuan\} and Nguyen, \{Xuan Khanh Thi\} and Guoying Bing and Bach, \{Jae Hyung\} and Park, \{Dae Hun\} and Keiichi Nakayama and Ali, \{Syed F.\} and Kanthasamy, \{Anumantha G.\} and Cadet, \{Jean L.\} and Toshitaka Nabeshima and Kim, \{Hyoung Chun\}",

note = "Funding Information: This study was supported by a Grant (\#2011K000271) from the Brain Research Center from 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and by a Grant (\#E00025) of the Korea-Japan Joint Research Program, National Research Foundation of Korea, Republic of Korea. This work was, in part, supported by grants from Ministry of Health Labour and Welfare (MHLW): Research on Risk of Chemical Substances, and Ministry of Education, Culture, Sports, Science and Technology (MEXT): Academic Frontier Project. Xuan-Khanh Thi Nguyen and Jae-Hyung Bach were supported by BK 21 Program.",

year = "2011",

month = aug,

doi = "10.1016/j.neuint.2011.03.022",

language = "English",

volume = "59",

pages = "39--50",

number = "1",

}

TY - JOUR

T1 - PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

AU - Shin, Eun Joo

AU - Duong, Chu Xuan

AU - Nguyen, Xuan Khanh Thi

AU - Bing, Guoying

AU - Bach, Jae Hyung

AU - Park, Dae Hun

AU - Nakayama, Keiichi

AU - Ali, Syed F.

AU - Kanthasamy, Anumantha G.

AU - Cadet, Jean L.

AU - Nabeshima, Toshitaka

AU - Kim, Hyoung Chun

N1 - Funding Information: This study was supported by a Grant (#2011K000271) from the Brain Research Center from 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and by a Grant (#E00025) of the Korea-Japan Joint Research Program, National Research Foundation of Korea, Republic of Korea. This work was, in part, supported by grants from Ministry of Health Labour and Welfare (MHLW): Research on Risk of Chemical Substances, and Ministry of Education, Culture, Sports, Science and Technology (MEXT): Academic Frontier Project. Xuan-Khanh Thi Nguyen and Jae-Hyung Bach were supported by BK 21 Program.

PY - 2011/8

Y1 - 2011/8

N2 - The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

AB - The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

KW - Dopaminergic toxicity

KW - Hyperthermia

KW - Methamphetamine

KW - PKCδ gene

KW - Phospho-TH at ser-40

KW - Striatum

UR - https://www.scopus.com/pages/publications/79960199029

UR - https://www.scopus.com/pages/publications/79960199029#tab=citedBy

U2 - 10.1016/j.neuint.2011.03.022

DO - 10.1016/j.neuint.2011.03.022

M3 - Article

C2 - 21672585

AN - SCOPUS:79960199029

SN - 0197-0186

VL - 59

SP - 39

EP - 50

JO - Neurochemistry International

JF - Neurochemistry International

IS - 1

ER -

PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto